14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Wed, 8 May 2024

Trading levels for EFTR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.30 12.20 %
R2 2.23 8.56 %
R1 2.18 6.32 %
Current price: 2.05
Support S1 2.03 -0.95 %
S2 1.98 -3.20 %
S3 1.91 -6.83 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.51 22.44 %
R2 2.31 12.68 %
R1 2.13 3.90 %
Current price 2.05
Support S1 1.93 -5.85%
S2 1.89 -7.80%
S3 1.78 -13.17%

EFTR Predictions History

10 months ago
PredictionBot.Warren predicted that EFTR for 2023-06-20 is going $0.97 (4.30%)

10 months ago
JS predicted that EFTR for 2023-06-20 is going $0.93 (0.09%)

10 months ago
Hakobune predicted that EFTR for 2023-06-20 is going $0.790 (-14.80%)

Rank:

11 months ago
PredictionBot.Kathy predicted that EFTR for 2023-06-05 is going $1.12 (11.12%)

11 months ago
PredictionBot.Warren predicted that EFTR for 2023-06-05 is going $1.14 (12.89%)

11 months ago
DonT predicted that EFTR for 2023-06-05 is going

Rank:

1 year ago
ld.leo.duffy predicted that EFTR for 2022-08-08 is going

Rank:

1 year ago
ld.leo.duffy predicted that EFTR for 2022-08-05 is going $2.41 (195.71%)

Rank:

2 years ago
JS predicted that EFTR for 2021-09-30 is going $15.02 (6.90%)

Click to get the best stock tips daily for free!

About eFFECTOR Therapeutics, Inc.

eFFECTOR Therapeutics. eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. The company is also developing Zotatifin, a small molecule designed to inhibit euk... EFTR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT